Navigating the Complex Landscape of Cell and Gene Therapy Manufacturing
By
Cheryl Scott
Source
bioprocessintl.comNavigating the Complex Landscape of Cell and Gene Therapy Manufacturingbioprocessintl.comYou might also wanna read
Manufacturing and regulatory hurdles threaten cell and gene therapy progress
The article discusses how manufacturing and regulatory challenges are hindering the progress of cell and gene therapies, particularly in can
medium.com·23d ago
How excessive FDA manufacturing requirements are bottlenecking cell and gene therapy companies
The article argues that excessive FDA manufacturing requirements are crippling cell and gene therapy companies, using Grace Therapeutics as
writingruxandrabio.com·4d ago
China creates new regulatory pathway to accelerate access to advanced biomedical therapies
China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and
biopharmadive.com·23d ago
How AI Will Transform Biopharma: The Sequence of Change Matters
Ben Liu, CEO of Formation Bio, argues that AI will transform the pharmaceutical industry unevenly and sequentially. Some parts of drug disco
a16z.news·17d ago
How AI and Emerging Biotechnologies Are Reshaping Global Biological Security Risks
The article examines how emerging biotechnologies like AI, synthetic biology, and biomanufacturing are reshaping the biological risk landsca
gmfus.org·22d ago
Precision gene editing technologies: From proof-of-concept to clinical therapies
This review article examines the evolution of gene therapy from gene addition to precise genome editing, focusing on breakthrough technologi
Comments
Sign in to join the conversation.
No comments yet. Be the first.